MiniMed Wins FDA Clearance for Its First Tubeless Insulin Pump
MiniMed's Fit pump just got the FDA's green light, giving the company its first tubeless option in automated insulin delivery. The device wears for up to seven days, holds 300 units and corrects glucose every five minutes. U.S. rollout starts with a phased launch in spring 2027.
- Original source: rttnews.com.
- The source published it on Nov 16, 2026 at 7:51 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
MiniMed said Monday the FDA cleared MiniMed Fit, its first tubeless insulin pump, adding a new device to its automated insulin delivery lineup. The system pairs up to seven days of wear with a 300-unit insulin capacity, smartphone app control and the company's SmartGuard technology.
MiniMed Fit is built for people with Type 1 and Type 2 diabetes aged seven and older. It adjusts insulin delivery on its own and can push correction doses every five minutes. A Meal Detection feature steps in with extra insulin when a meal dose gets skipped or comes up short.
Users get a choice of two sensors: Simplera Sync, rated for up to seven days of wear, and Abbott's Instinct sensor, which stretches to up to 15 days.
The company isn't rushing it to shelves. MiniMed expects a phased U.S. rollout in spring 2027, preceded by an early customer experience program planned for the fourth quarter of fiscal 2027.
Investors liked the news. MMED was trading at $18.67 on the Nasdaq, up $0.68, or 3.78 percent.
TopicsMiniMed · MMED · FDA · MiniMed Fit · SmartGuard · Simplera Sync · Abbott · Instinct
Source: rttnews.com
Written by AI from verified reporting.
More stories
- Health & science finance.yahoo.com 0 viewsNovartis' Cosentyx wins FDA nod as first anti-IL-17 biologic for PMR
- Health & science casrai.org 0 viewsFDA greenlights giredestrant-everolimus duo for ESR1-mutated breast cancer
- Health & science nbcnews.com Caught by @nina.anggraini29 0 viewsMeasles Is Endemic Again as the U.S. Loses Its Elimination Status
- Health & science aol.com 1 viewFDA Clears FoundationOne Liquid CDx as First Companion Test for WILSERDLY Combo

